Proactive – ImmuPharma “looking forward” with quiet confidence” to FDA response
24 May 2023
Tim McCarthy, CEO of ImmuPharma talks to Proactive Investors on the recent positive guidance from the FDA on its autoimmune program, CIDP – 24 May 2023
